Begins Coverage on China Pharma (NYSE:CPHI)

Research analysts at began coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a report released on Monday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of CPHI stock opened at $0.09 on Monday. The company has a quick ratio of 0.15, a current ratio of 0.82 and a debt-to-equity ratio of 0.23. China Pharma has a 1-year low of $0.08 and a 1-year high of $2.46. The company has a 50-day moving average of $0.12 and a two-hundred day moving average of $0.24.

China Pharma (NYSE:CPHIGet Free Report) last issued its earnings results on Monday, November 13th. The company reported ($0.06) earnings per share for the quarter. The business had revenue of $1.80 million for the quarter. China Pharma had a negative return on equity of 64.09% and a negative net margin of 39.99%.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Stories

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with's FREE daily email newsletter.